BBS-Bioactive Bone Substitutes Plc appointed Merja Haikola (MS Chem.) as Accountable director (QP) as of December 23, 2023. The current Quality Director Soile Hakala will leave the Company's service. Haikola has broad experience from similar positions in several companies in the pharmaceutical industry, including previous experience at BBS.
BBS-Bioactive Bone Substitutes Oyj
Equities
BONEH
FI4000260583
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.393 EUR | -0.25% | +2.88% | -19.63% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.63% | 8.21M | |
+8.29% | 124B | |
-5.61% | 11.02B | |
+4.83% | 8.88B | |
+39.60% | 5.45B | |
-22.04% | 4.74B | |
+8.39% | 3.44B | |
-6.28% | 2.84B | |
-10.23% | 2.15B | |
-5.99% | 2.11B |
- Stock Market
- Equities
- BONEH Stock
- News BBS-Bioactive Bone Substitutes Oyj
- BBS-Bioactive Bone Substitutes Plc Announces Director Changes